Lilly Gets Temporary Prozac Reprieve.(Eli Lilly and Co.'s Prozac patent extended)(Brief Article)

Chemical Market Reporter, November, 2000

THE FOOD AND Drug Administration has extended Eli Lilly & Co.'s patent on the antidepressant Prozac (fluoxetine) for an additional six months. The extension was granted since Lilly agreed to test the antidepressant on children. Under the FDA Modernization Act of 1997, pharmaceutical companies that comply with FDA requests for pediatric studies on selected medications can receive an extra six months of market exclusivity for those products.

Unless Lilly prevails with its pending appeal concerning the 2003 Prozac patent, the extension will begin February 2, 2001, upon the expiration of the 2001 Lilly Prozac, and will end August 2, 2001. During this time, no generic forms of the antidepressant will be allowed on the US market. Earlier this year,...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here